ObsEva SA (OBSV)

[Pan_O_War]

Obseva: In January, the Geneva-based biotech company saw three share purchases by one or more board members totaling almost half a million Swiss francs. The remarkable thing is that these are the first share purchases by company executives since December 2020. Last Friday, four days after the last of the three purchases, Obseva announced a capital increase, which sent the stock plunging as much as 16 percent at times on Monday.

Obseva shares have lost nearly 60 percent of their value over the past year and are currently trading at record lows. The company, whose market value is still just under 100 million francs, is being traded as a takeover candidate. A commitment is only suitable for extremely risk-capable investors.

source cash.ch